Schedule 13G ownership disclosure

VIRIOS THERAPEUTICS INC

Security class unavailable · CUSIP: 92829J104

Event date: 2022-09-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,830,000
Percent of class
9.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-22-001282
Form type
SC 13G
Filer
Ionic Ventures, LLC
CIK
CIK 1769419
Filed
Sep 21, 2022
Reporting period
Sep 20, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub